Credentials

PM Holding companies encompass the entire value chain that supports the Life Science companies to improve patients’ engagement and user experience through technology, data and streamlined processes.

We have outstanding achievements and experience in clinical trials from feasibility to submission, therapeutics development supported by innovative technologies, enabling data-driven management across the workflows involving Pharmacovigilance, achieving operational excellence via digital transformation and optimization, besides leveraging the competence of customers by consultancy and training services.

PM Holding companies offer fascinating career opportunities in Life Science for professionals and talents having a growth mindset and enjoying the diversity in a vibrant culture.
Arithmos is a PM Holding company of industry-leading experts in Life Science technology.

Life science companies trust Arithmos to drive the value of implementing technology solutions and services to support R&D operations smartly and more efficiently. With the experience that comes from accomplishing complex projects on EDC and RWE, Safety Solutions, Data Visualisation and Reporting, Extended Project and Portfolio Management Solution, Clinical Data Oversight, CTMS and DMS Arithmos is fully committed to improving its extensive integration capabilities to meet the future of Life Sciences.

Arithmos pursues digital solutions that fulfill the critical requirements of the clients and enable high-value business performance throughout the process automation, RWE, e-Health, IoT, and DCT projects.
Arithmos offers Technology Consultancy Services for:

With seasoned expertise and a holistic approach, driven by inherited knowledge in clinical development and regulatory, Arithmos supports its customers throughout the journey of:

Est. 2010

seQure is a PM Holding company supporting its customers in safeguarding patients’ health and improving their lives with innovative and efficient services.

Pharmaceuticals, biotech, medical device companies, hospitals, and institutions trust in seQure’s experience and competence to deliver the most convenient end-to-end services and solutions embracing Clinical, Pharmacovigilance, Quality Assurance and Auditing with a broad global network.

seQure promises an impeccable quality, unique attention to every detail and tailored solution  created to meet the specific needs of the clinical research per se.

seQure is a niche provider that offers Business Consultancy Services for:

seQure provides advanced personalised solutions for Quality and Compliance in GxP areas and supports its customers in designing the most effective system to meet regulatory requirements, reach their goals and improve their processes.

seQure guarantees a complete portfolio of pharmacovigilance services provided by a Team that boasts more than 25 years of experience.

seQure supports the customers in planning, conducting, reviewing, and maintaining the validation status of their applications through GxP assessment, validation planning, user requirement analysis and authoring as well as IQ/OQ/PQ authoring and execution including validation reports.

seQure supports the customers through all stages of drug development and product life cycle.

Est. 2014

CROS NT was founded by Paolo Morelli, and under his leadership the company became a global scaled CRO (Contract Research Organization) with offices in Italy, the UK, and the US, creating an outstanding difference in developing therapeutics for patients among more than 500 projects accomplished with success.

In June 2021, Alira Health, a leading international healthcare and life sciences advisory services firm, acquired CROS NT. 

This thrilling acquisition was a pivotal step for CROS NT, to contribute to Alira Health’s mission of healthcare transformation, creating value for patients. CROS NT brought global biometrics capabilities to Alira Health’s Regulatory, Clinical and Real-World Evidence (RWE) practices.

Paolo Morelli is still in Alira Health’s leadership team as the Executive Vice President, Biometrics. He is leading the growth of Alira Health’s Data Science services.

Joint Ventures

PM Holding owns other investments in companies and initiatives oriented in:

Meet our Team